Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
OncoVista Innovative Therapies, Inc.
OncoVista Innovative Therapies' Information to Be Available Through S&P Market Access Program
May 27th, 2008
OncoVista Innovative Therapies, Inc. (OTCBB:OVIT), a biopharmaceutical company engaged in the development and commercialization of targeted cancer therapies, announced that its company information will be made available via Standard & Poor's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of Standard & Poor's Advisor Insight. The company information to be made available through this program includes share price, volume, dividends, shares outstanding, company financial position, and earnings. Standard & Poor's Advisor Insight is an Internet-based research engine used by more...
Source: Cancer Weekly (2008-05-27)
|
